Diabetes & Metabolism

Diabetes mellitus and hypertension are two of the most common diseases in Westernized, industrialized civilizations, and the frequency of both diseases increases with increasing age. Diabetes mellitus is characterized by elevated blood glucose levels (hyperglycemia) resulting from defects in insulin secretion, insulin action or both, and associated with a considerably increased cardiovascular risk, peripheral vascular diseases, stroke, retinopathy, and nephropathy. Two types of diabetes mellitus are recognized based on the presumed etiology. In type 1 diabetes, the body fails to produce insulin as a result of an auto-immune reaction that destroys the islet cells in the pancreas that produce insulin, and daily insulin injections are required. Type 1 diabetes is usually diagnosed during childhood or early adolescence and it affects about 1 in every 600 children. Type 2 diabetes is the result of failure to produce sufficient insulin and insulin resistance. Elevated blood glucose levels are managed with reduced food intake, increased physical activity, and eventually oral medications or insulin. Type 2 diabetes is typically diagnosed during adulthood. However with the increasing incidence of childhood obesity and concurrent insulin resistance, the number of children diagnosed with type 2 diabetes has also increased worldwide.
The hallmark of hypertension in type I and type II diabetics appears to be increased peripheral vascular resistance. Increased exchangeable sodium may also play a role in the pathogenesis of blood pressure in diabetics. Evidence is accumulating that insulin resistance, or hyperinsulinemia, may play a key role in the pathogenesis of hypertension in both subtle and overt abnormalities of carbohydrate metabolism. Population studies suggest that elevated insulin levels, which often occurs in type II diabetes mellitus, is an independent risk factor for cardiovascular disease. Other cardiovascular risk factors in diabetic individuals include abnormalities of lipid metabolism, platelet function, and clotting factors.

Items 1 to 30 of 181 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Axon ID Name Description From price
1730 (+)-Kifunensine α-mannosidase inhibitor €120.00
2830 (R)-CE3F4 Potent inhibitor of EPAC1 €120.00
3743 (R)-HTS-3 hydrochloride First potent, selective, and cell-active LPCAT3 inhibitor €150.00
2537 1,5-Isoquinolinediol PARP1 inhibitor and neuroprotective agent €50.00
2175 3PO Inhibitor of HIF-1-induced PFKFB3, an enzyme with a key role in glycolysis. €65.00
1909 A 1070722 Selective inhibitor of GSK-3 €95.00
2059 A 922500 Highly potent and selective diacylglycerol acyltransferase 1 (DGAT-1) inhibitor €105.00
1873 Abiraterone Inhibitor of CYP17A1 €90.00
1874 Abiraterone acetate Prodrug of Abiraterone; Inhibitor of CYP17A1 €90.00
2552 Adjudin Non-hormonal male contraceptive with anti-proliferative activity €125.00
2746 AG-120 IDH1 mutant enzyme inhibitor €125.00
2745 AG-221 IDH2 mutant enzyme inhibitor €95.00
2122 AGI 5198 Inhibitor of R132 mutant isocitrate dehydrogenase 1 (IDH1) €60.00
2274 AGI 6780 Potent and selective inhibitor of the tumor-associated mutant IDH2 (R140Q) €90.00
2269 AK 1 Potent inhibitor of SIRT with good selectivity for SIRT2 over SIRT1 and SIRT3 €90.00
2270 AK 7 Potent, brain-permeable and selective inhibitor of SIRT2 €90.00
3310 Alogliptin benzoate Potent, highly selective and orally active DPP-4 inhibitor €65.00
2883 APPA Aldose reductase inhibitor €105.00
2819 APX-115 First-in-class pan-NADPH oxidase (Nox) inhibitor €125.00
2167 AR-A 014418 ATP-competitive GSK-3 inhibitor €85.00
2839 AS 1842856 Inhibitor of the Forkhead box protein O1 (FOXO1) €95.00
2578 ASB14780 Potent, orally available inhibitor of cPLA2α; antiinflammatory drug €130.00
2276 Atglistatin Potent and selective inhibitor of adipose triglyceride lipase (ATGL) €90.00
2043 Atorvastatin calcium Inhibitor of HMG-CoA reductase €60.00
2960 ATR-101 Potent, selective, and orally active ACAT1 inhibitor €145.00
2692 AX-024 hydrochloride T cell receptor inhibitor €125.00
5051 Axon Ligands™ Cell signaling and Oncology compound library Axon Ligands™ Cell signaling and Oncology compound library Inquire
5053 Axon Ligands™ Stem cell compound library Axon Ligands™ Stem cell compound library Inquire
2171 AZD1080 Selective inhibitor of GSK-3α and GSK-3β €90.00
3771 AZD2858 Potent and highly selective Glycogen Synthase Kinase-3β inhibitor €95.00

Items 1 to 30 of 181 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
Please wait...